Promoter Bank clone, Human myelin basic protein (MBP) promoter
Alternative name | p1973-12F |
---|---|
Clone info. | PCR amplified human myelin basic protein (MBP) promoter sequence was inserted into a Renilla luciferase reporter vector pKM2L (RDB04026). Cloned fragment: 77019999 to 77017024(NC_000018.10); relatively -2944 to +32, where +1 corresponds to 1 nt of NM_001025081.2. |
Comment | PCR cloning, forward primer, 1973 F2: 5' aggctgtgatacccctgctgttgct 3'; reverse primer, 1973 R2: 5' ggaggtggctgcactgtcttcttgg 3' Entire sequence of promoter region has not been confirmed. (reference: Brain Res. Dev. Brain Res., 65, 217-221, 1992, PMID:1373994; Gene, 313, 161-167, 2003, PMID:12957387; Gene, 75, 31-38, 1989, PMID:2470651) |
Vector backbone | pKM2L (RDB04026) (Plasmid) |
Size of vector backbone | 4.2 kb |
Selectable markers | Kan^r |
Gene/insert name | Human myelin basic protein (MBP) genomic DNA |
Depositor|Developer | DNA Bank, | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | 1. The RECIPIENT agrees to use the BIOLOGICAL RESOURCE only for academic research in the non-profit organization. 2. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Additional terms and conditions: The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 1. 本件リソースは学術研究機関にのみ提供し、学術研究にのみ利用することができる。 2. 謝辞の表明を必要とする。 MTAに書く付加的使用条件: 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB05890 | pKM2L-phMBP | DNA solution |
Materials & Methods section:
The pKM2L-phMBP was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB05890). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB13698_A5Jsp1.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: M13_-40 Sequence file: RDB13698_A5Jsa.seq |
---|
>05890_13698_A5Js_M13(-40)_D11_11.ab1 1 CCGGCAGCAG CTTGCATGCC TGCAGGTCAT TTAAATAGGG ATAACAGGGT AATGATTAAG 61 ATCTCGAGCT CTAAGCTTCA CATATGCATG CACTAGTGGC AGGCTGTGAT ACCCCTGCTG 121 TTGCTCACAG ATGGTCAGTT CCCTGCACAG GCCCTCCTGC CTCCCAGGTT ACTGCCTGGC 181 CTGGGAGGTT CTCAGCCCGG CCATCCTCCT GGACCCAGAA CCAGCATGGC CGCTCTCCTG 241 CTGCTTCCGC CACCGGGAGC CGATTCCGCG CAGGCTTCCA GTGGGGGCTG CCTTCCCCTC 301 TGCCAGAAGC ACCCTCCCCA ACTTCCCCAA GTCCTCGCAG GGCCCAGACT CTCATCTTGT 361 CCTGTCATTT CCGCAAGGAC CTTCCTGCTG ACCCAAGCCC TCTCTGCTTT CCTATTCTCT 421 TGCCTGATGT GAAGTTGCAC ATTGCATGAG TTGGGGCTGC CAAGACAAAT TACCATATGC 481 TGGGGGCTTC AAACTACAGG AATTCTTCTG TGACCATTGT GAAGGCCAGA AAGCTCAAGT 541 TGAGATGTCT GCAGAGCCCT GCTTCCCCCG AAGGCTCTAC AGGAGAATTT GCTCCATGTC 601 TCTTACTCCT GGTGGTGCTC AGAAGTGCTT GGTGTTCTGA GGTTTGTAGA TGCCCCCCTC 661 CAGGCTCCTC CTCCATCTTC ACACCTCTCC CCTGTGCATC TGTGGCTGTG TCCAAACTGC 721 TCTCTTCTTA CAAGGACACC AGTGATTGGA GTAGGGCCCA CCCTACTGCA GAATGACCTC 781 ATCTTCACTT GATTCCACCT GCAAAGATCT ATTTCCCAAA TAAAGGTCAC ACTCACAGGT 841 ACAGAAGTTA GGACATGGGA CATATCATTT GGAGGGATAC TATTTCAATC CCATAACATA 901 CATTTTCACC TGCTTTCCCC CACTAGAATG TAGTTTCACG AGGACAAGAC CTCGTGAGTA 961 CATCACTGTA CTCAGAATAT TTAGATGTAC ATTACATTAA TTTGTACTCA TAATTATTGG 1021 ATTGGATTGG ATTCATTGGT ATGTATGGTA TGTAACCAGG TACGCTTAAT TAGATTGG // |
Primer: phRLR2 Sequence file: RDB13698_A5Jsb.seq |
>05890_13698_A5Js_phRLR2_E11_14.ab1 1 ACTCCCGGTC TCGAAGCCCA GTTTCTATTG GTCTCCTTAA ACCTGTCTTG TAACCTTGAT 61 ACTTACCTGC CCAGTGCCTC ACGACCAACT TCTGCAGTAC CCGGGTGAAT TCTACGCGTC 121 GACAGGCGGA GGTGGCTGCA CTGTCTTCTT GGATGGTCTG GAGCTCGTCG GACTCAGAGG 181 GCCTGTCTTT GAAGGTGTTG TCCTCCCTCC CCGGGGCATC TCGGGAAAAG AGGCGGATCA 241 AGTGGGGGCG GCTCCCTGGG TCAGCTGGGT GGGCATCCTG CCAGGCATTC TTCGGGTCCG 301 CTGTGCGCTT GGAGTCAGTC ACCGCTGTGT CCTGAGAGGA GGTCCCATTG TTCTGGTTCG 361 CATCTGCCTC TCCTGCAAAC AACAATGAGA TATGAATACG GGCCTGTGCA AAGCTGAGCA 421 CCGGACAAAG CAGCTTTCTC TGAGGGGTCT TGACCTAGCT GTCTCCTATA AAACCCACAG 481 AATATGTGCA GTCCTCATAA AGCCCTTGGC CTAGGATGGA GCTAACCTGG ATGGAGCAGC 541 CTTATTGCAG CTCTGTGTTT CAGAAGGCTC TGGGAATTCC TCAGTTACTC GAGATTTGGC 601 ACCCAGCGTA AAATGCACCC AGGCTTCCCG ATGAAGTCAT CTGAGCATGC AGAGCAGCCA 661 CATCAGCGTT TCTTCCCGGG TGCTGCCATG GCTGCTCCCG GAGAGCCCAG ATGTGCAGGC 721 ACCTTGATGG GACATTGACT GTTTAAAAGG CCACTGGTGC ATAAGTTAAA TATGCAAGGA 781 GCATTTATTT GACAAAAGGT GTTTTTAGTT TTCTTGGTAG AAACAAAACT TGCCACATCT 841 TTTTGCAATT CATGCATGAA AGAAGTGGGG GCATTTAGAA TTGTTTCAAT CCCAGATTCC 901 ACAAGAGGCC TCTCACAATA GAGAACTGCT TATTCAGGAC ATTTTGACTT GGCTTCTCCT 961 CTGGGAAAGC AGAAACAAAT TAGAAATCTG AAAGTGGGAT TGAGATATTT CATGTTTGTA 1021 TACCCAGCAT CTCATAGCTT TTCCTCAAAA AAATACCACA TTTTCTTGTC ACGAAGGCCA 1081 ATTGCAACTC GATTTTGGCC TATCTAGTAC GAGTGATCAC GCATTTCAGA TCAT // |
Primer: pAxCALNL_F1 Sequence file: RDB13698_A5Jsc.seq |
>05890_13698_A5Js_pAxCALNL_F1_F11_17.ab1 1 ACATTATCTT ATCATGTCTG CTCGAGCGGC CGCTCTAGAA TTACTGCTCG TTCTTCAGCA 61 CGCGCTCCAC GAAGCTCTTG ATGTACTTAC CCATTTCATC TGGAGCGTCC TCCTGGCTGA 121 AGTGGAGGCC CTTCACCTTC ACGAACTCGG TGTTAGGGAA CTTCTTAGCT CCCTCGACAA 181 TAGCGTTGGA AAAGAACCCA GGGTCGGACT CGATGAACAT CTTAGGCAGA TCGTCGCTGG 241 CCCGAAGGTA GGCGTTGTAG TTGCGGACAA TCTGGACGAC GTCGGGCTTG CCTCCCTTAA 301 CGAGAGGGAT CTCGCGAGGC CAGGAGAGGG TAGGCCGTCT AACCTCGCCC TTCTCCTTGA 361 ATGGCTCCAG GTAGGCAGCG AACTCCTCAG GCTCCAGTTT CCGCATGATC TTGCTTGGGA 421 GCATGGTCTC GACGAAGAAG TTATTCTCAA GCACCATTTT CTCGCCCTCT TCGCTCTTGA 481 TCAGGGCGAT ATCCTCCTCG ATGTCAGGCC ACTCGTCCCA GGACTCGATC ACGTCCACGA 541 CACTCTCAGC ATGGACGATG GCCTTGATCT TGTCTTGGTG CTCGTAGGAG TAGTGAAAGG 601 CCAGACAAGC CCCCCAGTCG TGGCCCACAA AGATGATTTT CTTTGGAAGG TTCAGCAGCT 661 CGAACCAAGC GGTGAGGTAC TTGTAGTGAT CCAGGAGGCG ATATGAGCCA TTCCCGCTCT 721 TGCCGGACTT ACCCATTCCG ATCAGATCAG GGATGATGCA TCTAGCCACG GGCTCGATGT 781 GAGGCACGAC GTGCCTCCAC AGGTAGCTGG AGGCAGCGTT ACCATGCAGA AAAATCACGG 841 CGTTCTCGGC GTGCTTCTCG GAATCATAGT AGTTGATGAA GGGAGTCCAG CACGTTTCAT 901 TTGCTTGCAG CGAGCCTCAC TCACTGAGGC CCAGTGATCA TGCGTTTGCG TTTGCTCGGG 961 GTCGTACACC TTTGGAAGCC CATGGGTGGC TAGCTATAGT GAGTCGTATT AAGTACTCTA 1021 GCTTAGAGCT GTAATTGACC TGGGGAGTGG ACACCCTGTG GCAGAGAAAG CTAAGGTTGC 1081 AATGTTCAGG TAAGGACTCA T // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content